Related Experiment Video
Updated: Mar 23, 2026
Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
How Will New Guidelines Affect CD4 Testing in Veterans With HIV?
Paul G Barnett1,2,3, Susan K Schmitt1, Wei Yu1,3
1Health Economics Resource Center, Veterans Affairs Palo Alto Health Care System, Menlo Park.
Insights
Reducing routine CD4 testing for human immunodeficiency virus (HIV)-infected patients with controlled viral loads can save costs without impacting care quality. Further reductions in CD4 monitoring are warranted.
Area of Science:
- Infectious Diseases
- Immunology
- Public Health
Background:
- Current guidelines advocate for limited routine CD4 cell count testing in human immunodeficiency virus (HIV)-infected patients who have achieved viral control and are not immunocompromised.
- This shift aims to optimize resource allocation and patient management.
Purpose of the Study:
- To evaluate trends in CD4 testing frequency and associated costs among HIV-infected patients within the US Department of Veterans Affairs healthcare system.
- To assess the number, cost, and results of CD4 tests deemed optional or minimal under updated guidelines.
Main Methods:
- A retrospective analysis of CD4 and viral load tests from 28,530 HIV-infected patients receiving care between 2009 and 2013.
- Categorization of patients based on eligibility for optional or minimal CD4 monitoring according to established guidelines.
Main Results:
- CD4 testing frequency decreased by 10.8% over four years, yielding annual cost savings of approximately US$196,000.
- Full guideline implementation could further reduce CD4 testing by 28.9%, saving an additional US$600,000 annually.
- CD4 counts below 200 cells/µL were rare during periods of reduced monitoring (1.1% for minimal, 0.3% for optional).
Conclusions:
- Reducing CD4 monitoring in well-controlled HIV patients offers modest cost savings and may decrease patient anxiety with minimal impact on care quality.
- While significant progress has been made in reducing optional CD4 testing, further reductions are advisable.
Background:
Guidelines now recommend limited use of routine CD4 cell count testing in human immunodeficiency virus (HIV)-infected patients with successful viral control who are not immunocompromised.
Methods:
CD4 and viral load tests for patients receiving HIV care from the US Department of Veterans Affairs during 2009-2013 were evaluated to determine trends in CD4 testing frequency and the number, cost, and results of CD4 tests considered optional under the guidelines.
Results:
There were 28 530 individuals with sufficient testing to be included. At the time of the last CD4 test, 19.8% of the cohort was eligible for optional monitoring and 15.6% for minimal monitoring. CD4 testing frequency declined by 10.8% over 4 years, reducing the direct cost of testing by US$196 000 per year. Full implementation of new treatment guidelines could reduce CD4 testing a further 28.9%, an additional annual savings of US$600 000. CD4 tests conducted during periods of potentially reduced monitoring were rarely <200 cells/µL: 1.1% of the tests conducted when minimal monitoring was recommended and just 0.3% of tests conducted when optional monitoring was recommended were less than this value.
Conclusions:
Reduced CD4 monitoring of HIV-infected patients would result in modest cost savings and likely reduce patient anxiety, with little or no impact on the quality of care. Veterans Affairs has made substantial progress in reducing the frequency of optional CD4 testing, but further reductions may still be warranted.
